Damora Therapeutics, Inc.

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$21.01-$0.81 (-3.71%)

Jun 5, 2026

52W High $34.1452W Low $2.58

Company Details

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company's lead product includes DMR-001, a investigational monoclonal antibody therapy t...

CEO

—

IPO Date

Mar 10, 2026

Website

www.damoratx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$235M

EPS (Diluted)

Free Cash Flow

-$25M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 13, 2026

FY 2025

Mar 20, 2026

Q4 2025

Mar 20, 2026

Q3 2025

Nov 7, 2025

Q2 2025

Aug 6, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee